Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Paulsen

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
European Urology Oncology|November 17, 2021
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical TrialTobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Cancers|July 14, 2023
Increasing Patient Safety and Treatment Quality by Using Intraoperative MRI for Organ-Preserving Tumor Resection and High-Dose Rate Brachytherapy in Children with Bladder/Prostate and Perianal RhabdomyosarcomaAndreas Schmidt, Constantin Roder, Franziska Eckert, et al.
BMC Cancer|July 29, 2005
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definitionUte Ganswindt, Frank Paulsen, Stefan Corvin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trialStefan Welz, David Mönnich, Christina Pfannenberg, et al.
International Journal of Cancer|January 27, 2022
Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosisKatrin Ganser, Franziska Eckert, Andreas Riedel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2019
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer RadiotherapyDaniela Thorwarth, Stefan Welz, David Mönnich, et al.
Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
Cancers|May 14, 2022
Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)Tobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Journal of Clinical Medicine|October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System RelapseTim Flaadt, Martin Ebinger, Malin Schreiber, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2018
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell TransplantationDaniel Wegener, Peter Lang, Frank Paulsen, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
European Urology Oncology|November 17, 2021
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical TrialTobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Cancers|July 14, 2023
Increasing Patient Safety and Treatment Quality by Using Intraoperative MRI for Organ-Preserving Tumor Resection and High-Dose Rate Brachytherapy in Children with Bladder/Prostate and Perianal RhabdomyosarcomaAndreas Schmidt, Constantin Roder, Franziska Eckert, et al.
BMC Cancer|July 29, 2005
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definitionUte Ganswindt, Frank Paulsen, Stefan Corvin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trialStefan Welz, David Mönnich, Christina Pfannenberg, et al.
International Journal of Cancer|January 27, 2022
Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosisKatrin Ganser, Franziska Eckert, Andreas Riedel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2019
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer RadiotherapyDaniela Thorwarth, Stefan Welz, David Mönnich, et al.
Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
Cancers|May 14, 2022
Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)Tobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Journal of Clinical Medicine|October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System RelapseTim Flaadt, Martin Ebinger, Malin Schreiber, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2018
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell TransplantationDaniel Wegener, Peter Lang, Frank Paulsen, et al.
Pageof 12